Coverage
Filings
| Filing | Date |
|---|---|
| Director/PDMR Shareholding | 10 Oct 2024 |
| Holding(s) in Company | 4 Oct 2024 |
| Holding(s) in Company | 4 Oct 2024 |
| Director Declaration | 3 Oct 2024 |
| Completion of off-market purchase and Total Voting | 3 Oct 2024 |
| Update on purchase alongside Pfizer offering | 1 Oct 2024 |
| Divestment of NRT business outside US complete | 30 Sept 2024 |
| Total Voting Rights and Capital | 30 Sept 2024 |
Haleon on Monday announced that its chairman, Sir Dave Lewis, will step down at the end of the year to pursue a new executive role.
Haleon plc on Thursday announced it has released its trading statement for the third quarter of 2025.
| Proposed purchase alongside Pfizer offering |
| 30 Sept 2024 |
| Haleon to increase stake in China JV to 88% | 27 Sept 2024 |
| Director/PDMR Shareholding | 27 Sept 2024 |
| Transaction in Own Shares | 26 Sept 2024 |